MITOHEALTH, INC.

Basic Information

645 Meeting Street
CHARLESTON, SC, 29403-4279

Company Profile

n/a

Additional Details

Field Value
DUNS: 832752112
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 2


  1. Development of a lasmiditan analogue for treatment of acute kidney injury

    Amount: $232,938.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to develop a safe and efficacious therapeutic small molecule for treatment of acute kidney injury (AKI). AKI results from div ...

    SBIR Phase I 2014 Department of Health and Human Services
  2. Inducers of Mitochondrial Biogenesis

    Amount: $312,053.00

    DESCRIPTION (provided by applicant): The long-term goal of this project is to identify and develop drugs that induce mitochondrial biogenesis. A variety of diverse acute insults such as ischemia/reper ...

    SBIR Phase I 2011 Department of Health and Human Services
  3. High Throughput Mitochondrial Nephrotoxicant Assay

    Amount: $1,608,122.00

    DESCRIPTION (provided by applicant): The kidney is a target of toxicity from drugs, and industrial and environmental chemicals because of its high blood flow, numerous transporters, and reliance on a ...

    SBIR Phase II 2011 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government